S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
All the trading advice you’ve ever received boils down to this (Ad)
Closing prices for crude oil, gold and other commodities
Chick-fil-A Is Hiring an 'Entertainment Producer'
All the trading advice you’ve ever received boils down to this (Ad)
Dell, Marvell Technology fall; Ulta Beauty, UiPath rise, Friday, 12/1/2023
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
All the trading advice you’ve ever received boils down to this (Ad)
Closing prices for crude oil, gold and other commodities
Chick-fil-A Is Hiring an 'Entertainment Producer'
All the trading advice you’ve ever received boils down to this (Ad)
Dell, Marvell Technology fall; Ulta Beauty, UiPath rise, Friday, 12/1/2023
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
All the trading advice you’ve ever received boils down to this (Ad)
Closing prices for crude oil, gold and other commodities
Chick-fil-A Is Hiring an 'Entertainment Producer'
All the trading advice you’ve ever received boils down to this (Ad)
Dell, Marvell Technology fall; Ulta Beauty, UiPath rise, Friday, 12/1/2023
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
All the trading advice you’ve ever received boils down to this (Ad)
Closing prices for crude oil, gold and other commodities
Chick-fil-A Is Hiring an 'Entertainment Producer'
All the trading advice you’ve ever received boils down to this (Ad)
Dell, Marvell Technology fall; Ulta Beauty, UiPath rise, Friday, 12/1/2023
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections

ORIC Pharmaceuticals (ORIC) News Today

$8.27
+0.37 (+4.68%)
(As of 12/1/2023 ET)
Compare
Today's Range
$7.65
$8.30
50-Day Range
$5.41
$8.27
52-Week Range
$2.91
$9.79
Volume
412,571 shs
Average Volume
371,698 shs
Market Capitalization
$451.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.29
SourceHeadline
MarketBeat logoORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Consensus Rating of "Buy" from Analysts
americanbankingnews.com - November 24 at 1:24 AM
morningstar.com logoORIC Pharmaceuticals Inc ORIC
morningstar.com - November 9 at 8:00 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Werewolf Therapeutics (HOWL), Oric Pharmaceuticals (ORIC) and Acadia Healthcare (ACHC)
markets.businessinsider.com - November 8 at 2:03 PM
msn.com logoORIC Pharmaceuticals GAAP EPS of -$0.44
msn.com - November 6 at 9:49 PM
finance.yahoo.com logoORIC Pharmaceuticals Inc (ORIC) Reports Q3 2023 Financial Results and Operational Updates
finance.yahoo.com - November 6 at 9:49 PM
finance.yahoo.com logoORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
finance.yahoo.com - November 6 at 4:49 PM
finance.yahoo.com logoORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC-533 in Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting
finance.yahoo.com - November 2 at 9:17 AM
msn.com logoWedbush Reiterates ORIC Pharmaceuticals (ORIC) Outperform Recommendation
msn.com - October 23 at 10:05 PM
markets.businessinsider.com logoAnalyst Expectations for ORIC Pharmaceuticals's Future
markets.businessinsider.com - October 23 at 12:05 PM
finance.yahoo.com logoInitial Phase 1 Dose Escalation Data of ORIC-114 in Patients with EGFR and HER2 Exon 20 Mutations Demonstrates Potential Best-In-Class Profile
finance.yahoo.com - October 21 at 12:45 PM
finance.yahoo.com logoORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC 114 in EGFR/HER2 Exon 20 Mutated NSCLC at the European Society of Medical Oncology (ESMO) Congress 2023
finance.yahoo.com - October 17 at 8:27 PM
finance.yahoo.com logoOric Pharmaceuticals, Inc. (ORIC) Upgraded to Buy: What Does It Mean for the Stock?
finance.yahoo.com - October 16 at 2:01 PM
finance.yahoo.com logoNextRNA Therapeutics Strengthens Board of Directors with Appointment of Lori Friedman, PhD
finance.yahoo.com - September 26 at 11:41 AM
benzinga.com logoORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference
benzinga.com - September 20 at 7:47 PM
finance.yahoo.com logoORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference
finance.yahoo.com - September 20 at 7:47 PM
msn.com logoNavigating ORIC's Robust Strategy Against Cancer Drug Resistance
msn.com - September 13 at 9:18 PM
marketbeat.com logoAtom Investors LP Decreases Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)
marketbeat.com - September 11 at 6:26 AM
markets.businessinsider.com logoOric Pharmaceuticals (ORIC) Receives a Buy from Robert W. Baird
markets.businessinsider.com - August 17 at 8:10 AM
msn.com logoBaird Maintains ORIC Pharmaceuticals (ORIC) Outperform Recommendation
msn.com - August 16 at 10:10 PM
markets.businessinsider.com logoH.C. Wainwright Sticks to Its Buy Rating for Oric Pharmaceuticals (ORIC)
markets.businessinsider.com - August 15 at 8:13 AM
msn.com logoMarkets Today: Stocks Fall on a Hot U.S. July PPI
msn.com - August 11 at 3:50 PM
msn.com logoORIC Pharmaceuticals GAAP EPS of -$0.50 beats by $0.08
msn.com - August 11 at 6:56 AM
finance.yahoo.com logoORIC Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
finance.yahoo.com - August 11 at 1:55 AM
marketbeat.com logoVictory Capital Management Inc. Purchases New Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)
marketbeat.com - August 10 at 5:12 AM
finance.yahoo.com logoORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - August 4 at 7:19 PM
marketbeat.com logoJacob Chacko Sells 4,336 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Stock
marketbeat.com - July 7 at 5:36 PM
markets.businessinsider.com logoWhy Oric Pharmaceuticals Stock Is Shooting Higher Today
markets.businessinsider.com - June 28 at 9:46 AM
finance.yahoo.com logoWhy Shares of Oric Pharmaceuticals Jumped Monday
finance.yahoo.com - June 26 at 5:40 PM
seekingalpha.com logoORIC Pharmaceuticals launches ~$85M private placement of shares, warrants
seekingalpha.com - June 26 at 12:39 PM
markets.businessinsider.com logoORIC Pharma Surges On $85 Mln Private Placement Financing
markets.businessinsider.com - June 26 at 12:39 PM
finance.yahoo.com logoORIC Pharmaceuticals Announces $85 Million Private Placement Financing
finance.yahoo.com - June 26 at 12:39 PM
msn.com logoHC Wainwright & Co. Reiterates ORIC Pharmaceuticals (ORIC) Buy Recommendation
msn.com - June 8 at 6:17 PM
marketbeat.com logoCornercap Investment Counsel Inc. Sells 22,606 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)
marketbeat.com - June 2 at 8:26 AM
finance.yahoo.com logoORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference
finance.yahoo.com - May 31 at 4:39 PM
msn.com logoHC Wainwright & Co. Maintains ORIC Pharmaceuticals (ORIC) Buy Recommendation
msn.com - May 12 at 10:43 AM
marketbeat.com logoORIC Pharmaceuticals, Inc. Forecasted to Post Q2 2023 Earnings of ($0.59) Per Share (NASDAQ:ORIC)
marketbeat.com - May 12 at 7:55 AM
msn.com logoORIC Pharmaceuticals GAAP EPS of -$0.53
msn.com - May 8 at 9:21 PM
finance.yahoo.com logoORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
finance.yahoo.com - May 8 at 4:21 PM
finance.yahoo.com logoORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - May 5 at 7:16 PM
marketbeat.com logoBank of Montreal Can Invests $636,000 in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)
marketbeat.com - May 1 at 4:49 AM
finance.yahoo.com logoORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Investor Conference
finance.yahoo.com - April 25 at 6:47 PM
marketbeat.com logoMonaco Asset Management SAM Raises Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)
marketbeat.com - April 20 at 4:53 AM
finance.yahoo.com logoORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting
finance.yahoo.com - April 18 at 8:32 PM
msn.com logoCitigroup Maintains ORIC Pharmaceuticals (ORIC) Buy Recommendation
msn.com - April 6 at 9:00 AM
finance.yahoo.com logoOne ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) insider upped their stake by 128% in the previous year
finance.yahoo.com - March 31 at 12:42 PM
finance.yahoo.com logo‘Charts Point to Higher Highs,’ Says Oppenheimer. Here Are 2 Stocks With Over 100% Upside Potential
finance.yahoo.com - March 29 at 11:50 PM
marketbeat.com logoQ1 2023 Earnings Estimate for ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Issued By HC Wainwright
marketbeat.com - March 24 at 6:17 AM
markets.businessinsider.com logo4 Analysts Have This to Say About ORIC Pharmaceuticals
markets.businessinsider.com - March 23 at 12:01 PM
marketbeat.com logoORIC Pharmaceuticals (NASDAQ:ORIC) Given New $15.00 Price Target at JPMorgan Chase & Co.
marketbeat.com - March 21 at 10:32 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Neoleukin Therapeutics (NLTX), RAPT Therapeutics (RAPT) and Oric Pharmaceuticals (ORIC)
markets.businessinsider.com - March 21 at 7:34 AM
Get ORIC Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ORIC and its competitors with MarketBeat's FREE daily newsletter.



ORIC Media Mentions By Week

ORIC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ORIC
News Sentiment

1.87

0.76

Average
Medical
News Sentiment

ORIC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ORIC Articles
This Week

1

1

ORIC Articles
Average Week

Get ORIC Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ORIC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ORIC) was last updated on 12/2/2023 by MarketBeat.com Staff

My Account -